{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:45:22Z","timestamp":1783748722461,"version":"3.55.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0195629","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T14:00:48Z","timestamp":1523541648000},"page":"e0195629","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Overview and outcome of Hodgkin\u2019s Lymphoma: Experience of a single developing country\u2019s oncology centre"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8964-7497","authenticated-orcid":true,"given":"Rawand P.","family":"Shamoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Dahir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazar P.","family":"Shabila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/annonc\/mdf652","article-title":"Epidemiology and etiology of Hodgkin\u2019s lymphoma","volume":"13","author":"R Thomas","year":"2002","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2014.048","article-title":"Epidemiological overview of Hodgkin lymphoma across the mediterranean basin","volume":"6","author":"M Salati","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MPH.0b013e318271f587","article-title":"Hodgkin lymphoma in children: experience in a tertiary care centre in India","volume":"35","author":"A Trehan","year":"2013","journal-title":"J Pediat Hematol Onc"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/MPH.0b013e3181bdf1f3","article-title":"Pediatric lymphoma: a 10-year experience at a tertiary care hospital in Pakistan","volume":"32","author":"Z Fadoo","year":"2010","journal-title":"J Pediat Hematol Onc"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/02841860802310991","article-title":"The treatment of childhood Hodgkin lymphoma: improved survival in a developing country","volume":"48","author":"M B\u00fcy\u00fckpamuk\u00e7u","year":"2009","journal-title":"Acta Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3109\/08880019509030770","article-title":"Treatment results of Hodgkin\u2019s disease in Indian children","volume":"12","author":"G Kapoor","year":"1995","journal-title":"Pediatr Hematol Oncol"},{"key":"ref7","article-title":"Prognostic factors and treatment results of pediatric Hodgkin\u2019s lymphoma: A single center experience","volume":"57","author":"S B\u00fcy\u00fckkapu-Bay","year":"2015","journal-title":"Turk J Pediatr"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000670","article-title":"Hodgkin lymphoma in childhood: clinicopathological features and therapy outcome at 2 centers from a developing country","volume":"94","author":"LM Sherief","year":"2015","journal-title":"Medicine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7314\/APJCP.2016.17.1.101","article-title":"Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia","volume":"17","author":"A Avagyan","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000460819","article-title":"Hodgkin Lymphoma Outcome: A Retrospective Study from 3 Tertiary Centers in Saudi Arabia","volume":"40","author":"RG Shafi","year":"2017","journal-title":"Oncol Res Treat"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/pbc.25935","article-title":"ABVD-Based Therapy for Hodgkin Lymphoma in Children and Adolescents: Lessons Learnt in a Tertiary Care Oncology Center in a Developing Country","volume":"63","author":"S Jain","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0959-8049(96)00518-7","article-title":"Survival analysis of patients with clinical stages I or II Hodgkin\u2019s disease who have relapsed after initial treatment with radiotherapy alone","volume":"33","author":"A Horwich","year":"1997","journal-title":"Eur J Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000360205","article-title":"The challenging aspects of managing adolescents and young adults with Hodgkin\u2019s lymphoma","volume":"132","author":"RD Jachimowicz","year":"2014","journal-title":"Acta Haematol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/10428190601078118","article-title":"PET and PET\/CT for response evaluation in lymphoma: current practice and developments","volume":"48","author":"L Brepoels","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00428-013-1442-0","article-title":"Thomas Hodgkin: the \u201cman\u201d and \u201chis disease\u201d: humani nihil a se alienum putabit (nothing human was foreign to him)","volume":"463","author":"SA Geller","year":"2013","journal-title":"Virchows Arch"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3322\/caac.21235","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"CE DeSantis","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"ref17","article-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"S Swerdlow","year":"2008"},{"key":"ref18","first-page":"1860","article-title":"Report of the committee on Hodgkin\u2019s disease staging classification","volume":"31","author":"PP Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/10428190802663205","article-title":"How much does it cost to treat children with Hodgkin lymphoma in Africa?","volume":"50","author":"DC Stefan","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1200\/JCO.2002.03.051","article-title":"Treatment of unfavorable childhood Hodgkin\u2019s disease with VEPA and low-dose, involved-field radiation","volume":"20","author":"AM Friedmann","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref21","article-title":"The lymphomas","author":"AL Feldman","year":"2006"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1200\/JCO.2004.01.021","article-title":"Consolidation radiation after complete remission in Hodgkin\u2019s disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?","volume":"22","author":"S Laskar","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1008200210674","article-title":"Treatment of childhood Hodgkin\u2019s disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua","volume":"8","author":"F Baez","year":"1997","journal-title":"Ann Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jcp.53.3.182","article-title":"Improved prognosis of Epstein-Barr virus associated childhood Hodgkin\u2019s lymphoma: study of 47 South African cases","volume":"53","author":"M Engel","year":"2000","journal-title":"J Clin Pathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1200\/JCO.2005.05.2746","article-title":"Combined-modality therapy for clinical stage I or II Hodgkin\u2019s lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials","volume":"24","author":"EM Noordijk","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3109\/08880018.2013.823471","article-title":"Differences between younger and older patients with childhood Hodgkin lymphoma","volume":"30","author":"A Pourtsidis","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"key":"ref27","first-page":"448","article-title":"Hodgkin\u2019s lymphoma","volume":"35","author":"MS Fadhil","year":"2014","journal-title":"Saudi Med J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","article-title":"Characteristics of Hodgkin\u2019s lymphoma after infectious mononucleosis","volume":"349","author":"H Hjalgrim","year":"2003","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0609.2005.00451.x","article-title":"Pathogenesis of Hodgkin\u2019s lymphoma","volume":"75","author":"R K\u00fcppers","year":"2005","journal-title":"Eur J Haematol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T","article-title":"Epstein-Barr virus-associated Hodgkin\u2019s disease: Epidemiologic characteristics in international data","volume":"70","author":"SL Glaser","year":"1997","journal-title":"Int J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3109\/10428194.2010.525724","article-title":"Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988\u20132005: an analysis of 21 734 cases","volume":"51","author":"F Bazzeh","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"ref32","article-title":"Changing patterns in the clinical pathological features of hodgkin lymphoma: a report from debrecen, hungary","author":"Z Milt\u00e9nyi","year":"2011","journal-title":"ISRN Hematol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/pbc.20157","article-title":"Hodgkin\u2019s disease in Indian children: Outcome with chemotherapy alone","volume":"46","author":"LS Arya","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2967\/jnumed.109.073197","article-title":"18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma","volume":"51","author":"JJ Cerci","year":"2010","journal-title":"J Nucl Med"},{"key":"ref35","first-page":"1270","article-title":"Epidemiological features of childhood cancers in greater Mumbai","volume":"38","author":"B Yeole","year":"2001","journal-title":"Indian Pediatr"},{"key":"ref36","first-page":"98","article-title":"Clinical characteristics and therapy outcome of pediatric Hodgkin\u2019s lymphoma-a single centre experience from the west part of Turkey","volume":"37","author":"KM Uysal","year":"2007","journal-title":"Turk J Cancer"},{"key":"ref37","unstructured":"NCCN clinical practice guidelines in oncology. Hodgkin\u2019s Disease\/Lymphoma V2.2009. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nccn.org\" xlink:type=\"simple\">www.nccn.org<\/ext-link>."},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdp144","article-title":"Hodgkin\u2019s lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20","author":"A Engert","year":"2009","journal-title":"Ann Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"iii70","DOI":"10.1093\/annonc\/mdu181","article-title":"Hodgkin\u2019s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"D Eichenauer","year":"2014","journal-title":"Ann Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3324\/haematol.2009.015644","article-title":"Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin\u2019s lymphoma: a systematic review","volume":"95","author":"C Herbst","year":"2010","journal-title":"Haematologica"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1182\/blood-2016-02-699850","article-title":"Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma","volume":"128","author":"R Chen","year":"2016","journal-title":"Blood"},{"issue":"special issue 1","key":"ref42","first-page":"85","article-title":"Serum Lactic Dehydrogenase (LDH) Activity in Lymphomas: Prognostic Significance and Relationship to Presentation, Stage and Histologic Type","volume":"14","author":"RP Shamoon","year":"2010","journal-title":"Zanco J. Med. Sci"},{"key":"ref43","article-title":"Hodgkin lymphoma in children, adolescents and young adults\u2014a comparative study of clinical presentation and treatment outcome","author":"A Englund","year":"2017","journal-title":"Acta Oncol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1200\/JCO.2003.07.124","article-title":"Prognostic factors for children with Hodgkin\u2019s disease treated with combined-modality therapy","volume":"21","author":"RS Smith","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0195629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T11:12:25Z","timestamp":1540206745000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0195629"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0195629","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]}}}